Li PK et al. |
The complications of newer transplant antirejection drugs: treatment with cyclosporin A, OKT3, and FK506. |
1990 |
Adverse Drug React Acute Poisoning Rev |
pmid:1703724
|
Shapiro R et al. |
The side effects of FK 506 in humans. |
1990 |
Transplant. Proc. |
pmid:1689892
|
Van Thiel DH et al. |
Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689893
|
Mieles L et al. |
Oral glucose tolerance test in liver recipients treated with FK 506. |
1990 |
Transplant. Proc. |
pmid:1689894
|
Alessiani M et al. |
Infections with FK 506 immunosuppression: preliminary results with primary therapy. |
1990 |
Transplant. Proc. |
pmid:1689895
|
Staschak S et al. |
A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent. |
1990 |
Transplant. Proc. |
pmid:1689896
|
|
Second International Workshop on FK 506. A potential breakthrough in immunosuppression: clinical implications. October 31, 1989, Barcelona, Spain. Proceedings. |
1990 |
Transplant. Proc. |
pmid:1689897
|
Cadoff EM et al. |
Assay of FK 506 in plasma. |
1990 |
Transplant. Proc. |
pmid:1689898
|
Venkataramanan R et al. |
Pharmacokinetics of FK 506: preclinical and clinical studies. |
1990 |
Transplant. Proc. |
pmid:1689899
|
Jain AB et al. |
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. |
1990 |
Transplant. Proc. |
pmid:1689900
|
Fung JJ et al. |
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. |
1990 |
Transplant. Proc. |
pmid:1689901
|
Rosen MK et al. |
Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate. |
1990 |
Science |
pmid:1693013
|
Thomas FT et al. |
Comparative efficacy of immunosuppressive drugs in xenografting. |
1990 |
Transplant. Proc. |
pmid:1693452
|
Harrison RK and Stein RL |
Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes. |
1990 |
Biochemistry |
pmid:1693856
|
Starzl TE et al. |
Kidney transplantation under FK 506. |
1990 |
JAMA |
pmid:1693970
|
Bierer BE et al. |
Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction. |
1990 |
Transplantation |
pmid:1694317
|
Eiras G et al. |
Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506. |
1990 |
Transplantation |
pmid:1694318
|
Tze WJ et al. |
In vitro effects of FK-506 on human and rat islets. |
1990 |
Transplantation |
pmid:1694319
|
Maki N et al. |
Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin. |
1990 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1695378
|
Doe SE et al. |
Early effects of the immunosuppressive drug FK-506 on signal transduction in lymphocytes. |
1990 |
Biochem. Soc. Trans. |
pmid:1695581
|
Okubo Y et al. |
FK506, a novel immunosuppressive agent, induces antigen-specific immunotolerance in active Heymann's nephritis and in the autologous phase of Masugi nephritis. |
1990 |
Clin. Exp. Immunol. |
pmid:1702373
|
Arita C et al. |
Inhibition by FK506 of established lesions of collagen-induced arthritis in rats. |
1990 |
Clin. Exp. Immunol. |
pmid:1702374
|
Woo J et al. |
Influence of FK506 and cyclosporin A on alloantibody production and lymphocyte activation following blood transfusion. |
1990 |
Clin. Exp. Immunol. |
pmid:1702375
|
Mattila PS et al. |
The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. |
1990 |
EMBO J. |
pmid:1702384
|
Kawashima H et al. |
Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat. |
1990 |
Invest. Ophthalmol. Vis. Sci. |
pmid:1702408
|
Wilkinson PC and Watson EA |
FK506 and pertussis toxin distinguish growth-induced locomotor activation from attractant-stimulated locomotion in human blood lymphocytes. |
1990 |
Immunology |
pmid:1702750
|
Metcalfe S and Milner J |
Phosphatases PP1 and PP2A act after the G0/G1 interface in lymphocyte activation. |
1990 |
Immunol. Lett. |
pmid:1702753
|
Takada K et al. |
Determination of a novel potent immunosuppressant (FK-506) in rat serum and lymph by high-performance liquid chromatography with chemiluminescence detection. |
1990 |
J. Chromatogr. |
pmid:1703552
|
Akutsu I et al. |
[Inhibitory effect of FK-506 on the development of late asthmatic response and on the increased bronchial responsiveness]. |
1990 |
Arerugi |
pmid:1705791
|
Fung JJ et al. |
Overview of FK506 in transplantation. |
1990 |
Clin Transpl |
pmid:1715740
|
Wasik M et al. |
Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses. |
1990 Jul-Aug |
Immunopharmacology |
pmid:1699911
|
MacLeod AM and Thomson AW |
[FK-506. A new immunosuppressive drug]. |
1990 Jul-Sep |
Medicina (Firenze) |
pmid:1706817
|
Naouri A and Tissot E |
[Indications for liver transplantation in adults]. |
1990 Jun-Jul |
J Chir (Paris) |
pmid:1698800
|
Gailliot FP et al. |
Fluidized bed adsorption for whole broth extraction. |
1990 Sep-Oct |
Biotechnol. Prog. |
pmid:1366874
|
Siekierka JJ et al. |
Potential roles of other FK 506-binding proteins in mediating the effects of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721256
|
Morris RE |
In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use. |
1991 |
Transplant. Proc. |
pmid:1721257
|
Kobayashi M et al. |
FK 506 assay past and present--characteristics of FK 506 ELISA. |
1991 |
Transplant. Proc. |
pmid:1721258
|
Warty VS et al. |
Practical aspects of FK 506 analysis (Pittsburgh experience). |
1991 |
Transplant. Proc. |
pmid:1721259
|
Jusko WJ and D'Ambrosio R |
Monitoring FK 506 concentrations in plasma and whole blood. |
1991 |
Transplant. Proc. |
pmid:1721260
|
Blanc P et al. |
Antiproliferative effect of FK 506 and cyclosporine on adult human hepatocytes in culture. |
1991 |
Transplant. Proc. |
pmid:1721288
|
Loréal O et al. |
FK 506 is less cytotoxic than cyclosporine to human and rat hepatocytes in vitro. |
1991 |
Transplant. Proc. |
pmid:1721289
|
McCauley J et al. |
Cyclosporine and FK 506 induced inhibition of renal epithelial cell proliferation. |
1991 |
Transplant. Proc. |
pmid:1721290
|
McLachlan G et al. |
Growth inhibition of the MOLT-4 human T-leukemia cell line. A comparison of cyclosporine and FK 506. |
1991 |
Transplant. Proc. |
pmid:1721291
|
Akselband Y et al. |
Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts. |
1991 |
Transplant. Proc. |
pmid:1721292
|
Schreiber SL et al. |
Immunophilin-ligand complexes as probes of intracellular signaling pathways. |
1991 |
Transplant. Proc. |
pmid:1721293
|
Chen-Woan M et al. |
Diminished lymphocyte growth from endomyocardial biopsies from cardiac transplant patients on FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721320
|
Fukuzawa M et al. |
Effect of FK 506 on CD4+ and CD8+ T-cell function in vivo. |
1991 |
Transplant. Proc. |
pmid:1721321
|
Takaori K et al. |
Effects of FK 506 on in vivo immunity in comparison to cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721322
|
Jordan ML et al. |
Inhibition of T-cell function by FK 506 and cyclosporine is not accompanied by alterations in intracellular calcium. |
1991 |
Transplant. Proc. |
pmid:1721323
|
Motta I et al. |
FK 506 favors the generation of memory T cells in vitro. |
1991 |
Transplant. Proc. |
pmid:1721324
|
Green M et al. |
Infectious complications of pediatric liver transplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1721352
|
Carroll PB et al. |
Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans. |
1991 |
Transplantation |
pmid:1702911
|
Torre-Cisneros J et al. |
The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721353
|
Starzl TE et al. |
Hepatotrophic effects of FK506 in dogs. |
1991 |
Transplantation |
pmid:1702912
|
Paul AA et al. |
CMV retinitis and the use of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721354
|
Keicho N et al. |
Effects of an immunosuppressant, FK506, on interleukin 1 alpha production by human macrophages and a macrophage-like cell line, U937. |
1991 |
Cell. Immunol. |
pmid:1703047
|
Reyes J et al. |
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721355
|
White DJ |
FK506: the promise and the paradox. |
1991 |
Clin. Exp. Immunol. |
pmid:1703053
|
Whiteside TL et al. |
Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506. |
1991 |
Transplant. Proc. |
pmid:1721356
|
Frayha HH et al. |
Lymphoproliferative disorder in a liver transplant patient on FK 506. |
1991 |
Lancet |
pmid:1703258
|
McCauley J et al. |
Changes in renal function after liver transplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1721385
|
Tauxe WN et al. |
A comparison of the renal effects (ERPF, GFR, and FF) of FK 506 and cyclosporine in patients with liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721386
|
McCauley J et al. |
Renal function after conversion from cyclosporine to FK 506 in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721387
|
Hossein-Nia M et al. |
Urinary proteins as a marker of drug-induced renal damage following treatment with cyclosporine or FK 506. |
1991 |
Transplant. Proc. |
pmid:1721388
|
Winkler M et al. |
Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients. |
1991 |
Transplant. Proc. |
pmid:1721389
|
Schmidt RJ et al. |
Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721390
|
Fukuzaki T et al. |
Induction of tolerance to islet allografts with preoperative donor spleen cell injection and a short course of FK 506 treatment. |
1991 |
Transplant. Proc. |
pmid:1721415
|
Tzakis AG et al. |
FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. |
1991 |
Transplant. Proc. |
pmid:1721416
|
Masaoka T et al. |
Phase II study of FK 506 for allogeneic bone marrow transplantation. |
1991 |
Transplant. Proc. |
pmid:1721417
|
Markus PM et al. |
The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation. |
1991 |
Transplant. Proc. |
pmid:1721418
|
Cooper MH et al. |
The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. |
1991 |
Transplant. Proc. |
pmid:1721419
|
Brabletz T et al. |
The immunosuppressives FK 506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer. |
1991 |
Nucleic Acids Res. |
pmid:1707162
|
Iwaki Y et al. |
Replacement of donor lymphoid tissue in small-bowel transplants. |
1991 |
Lancet |
pmid:1707470
|
Markus PM et al. |
Effects of in vivo treatment with FK506 on natural killer cells in rats. |
1991 |
Transplantation |
pmid:1707562
|
Lin CS et al. |
FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes. |
1991 |
Cell. Immunol. |
pmid:1707760
|
Vincent SH et al. |
Effects of the immunosuppressant FK-506 and its analog FK-520 on hepatic and renal cytochrome P450 mixed-function oxidase. |
1991 |
Biochem. Pharmacol. |
pmid:1708254
|
Fabrega AJ et al. |
FK 506 enhances the beneficial effects of donor-specific blood transfusion on allograft survival in rats. |
1991 |
Transplant. Proc. |
pmid:1721447
|
Davies CB et al. |
Effects of donor-specific transfusion, cyclosporine A and FK 506 on rat cardiac allograft survival. |
1991 |
Transplant. Proc. |
pmid:1721448
|
Abu-Elmagd K et al. |
FK 506: a new therapeutic agent for severe recalcitrant psoriasis. |
1991 |
Transplant. Proc. |
pmid:1721449
|
Nikolaidis NL et al. |
Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases. |
1991 |
Transplant. Proc. |
pmid:1721450
|
Abu-Elmagd K et al. |
Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. |
1991 |
Transplant. Proc. |
pmid:1721451
|
Markus PM et al. |
FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats. |
1991 |
Surgery |
pmid:1713358
|
Farley DE et al. |
The effect of two new immunosuppressive agents, FK506 and didemnin B, in murine pregnancy. |
1991 |
Transplantation |
pmid:1713360
|
Vathsala A et al. |
The immunosuppressive antagonism of low doses of FK506 and cyclosporine. |
1991 |
Transplantation |
pmid:1713361
|
Kawano K et al. |
A protective effect of FK506 in ischemically injured rat livers. |
1991 |
Transplantation |
pmid:1713362
|
Armitage JM et al. |
Preliminary experience with FK506 in thoracic transplantation. |
1991 |
Transplantation |
pmid:1713363
|
Ochiai T et al. |
[Immunosuppressive agents--advances of the developmental studies and the mode of action]. |
1991 |
Nippon Rinsho |
pmid:1715926
|
Ricordi C et al. |
In vivo effect of FK506 on human pancreatic islets. |
1991 |
Transplantation |
pmid:1716797
|
Katz IA et al. |
Comparison of the effects of FK506 and cyclosporine on bone mineral metabolism in the rat. A pilot study. |
1991 |
Transplantation |
pmid:1716801
|
Jiang H et al. |
Effect of FK-506 on heart allograft survival in the highly sensitized recipient rats as compared with ciclosporin and 15-deoxyspergualin. |
1991 |
Eur Surg Res |
pmid:1723683
|
Pezze JL and Whiteman K |
Transplantation's newest weapon FK 506. |
1991 |
Am J Nurs |
pmid:1716857
|
Fung JJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. |
1991 |
Transplant. Proc. |
pmid:1703682
|
Marquis-Omer D et al. |
Stabilization of the FK506 binding protein by ligand binding. |
1991 |
Biochem. Biophys. Res. Commun. |
pmid:1716886
|
Wu J et al. |
Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation. |
1991 |
Transplant. Proc. |
pmid:1703683
|
Sakai K et al. |
[The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents--comparison with cyclosporin A]. |
1991 |
No To Shinkei |
pmid:1716937
|
Altmeyer A et al. |
Unexpected up-regulation of gene expression by cyclosporin A and FK-506 in a T-cell lymphoma: both immunosuppressants augment Ly-6E antigen induction by interferon-gamma in the presence of ionomycin. |
1991 |
Int. J. Immunopharmacol. |
pmid:1726093
|
Gordon RD et al. |
Liver transplantation at the University of Pittsburgh, 1984 to 1990. |
1991 |
Clin Transpl |
pmid:1726458
|
Jamieson NV et al. |
Orthotopic liver transplantation at Addenbrooke's Hospital Cambridge 1968 to 1991. |
1991 |
Clin Transpl |
pmid:1726459
|
Takahara S et al. |
Survival of cardiac allograft in highly sensitized and nonsensitized rats treated with FK506. |
1991 |
J Clin Lab Immunol |
pmid:1726566
|
Stötter H and Lotze MT |
Human lymphokine-activated killer cell activity. Role of IL-2, IL-4, and IL-7. |
1991 |
Arch Surg |
pmid:1726819
|